Related Experiment Video
Updated: May 19, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Design and analysis issues of multiregional clinical trials with different regional primary endpoints
Hsiao-Hui Tsou1, Yi Tsong, Wan-Jung Chang
1Division of Biostatistics and Bioinformatics, Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Miaoli County, Taiwan. tsouhh@nhri.org.tw
Abstract:
One of the challenges of multiregional drug development program is to design and analyze a multiple regional clinical trial with the objective being to satisfy different regional requirements on primary endpoints. Considered in this article is a multiregional clinical trial (MRCT) designed to test for two primary endpoints. Data of a regular fixed-size well-controlled parallel arm trial are used to test for two null hypotheses in terms of two distinct yet correlated endpoints. The two hypotheses may be tested sequentially or simultaneously. Depending on the structure of the hypotheses to be tested and the understanding of type I error rate control, various scenarios of type I error rate adjustments may be applied. Furthermore, for the objective of getting approval from regional authorities for different primary endpoints, various sample size and power determinations may be applied. In this article, comparisons of different approaches are discussed systematically.
Insights
Designing multiregional clinical trials (MRCTs) for two primary endpoints presents challenges. This study systematically compares various approaches for hypothesis testing, error rate control, and sample size determination to meet diverse regional requirements.
Area of Science:
- Clinical Trials
- Biostatistics
- Drug Development
Background:
- Multiregional clinical trials (MRCTs) face challenges in satisfying diverse regional requirements for primary endpoints.
- Designing and analyzing trials with multiple primary endpoints requires careful consideration of statistical methodologies.
Purpose of the Study:
- To systematically compare different statistical approaches for multiregional clinical trials (MRCTs) with two primary endpoints.
- To address the objective of satisfying distinct regional requirements for primary endpoints in drug development programs.
Main Methods:
- Utilized data from a standard fixed-size, well-controlled parallel arm trial.
- Evaluated sequential and simultaneous testing of two null hypotheses for distinct, correlated endpoints.
- Compared various type I error rate adjustment strategies and sample size/power determination methods.
Main Results:
- Demonstrated systematic comparisons of different statistical approaches for MRCTs with dual primary endpoints.
- Highlighted the impact of hypothesis structure and error rate control on overall trial design.
- Discussed the implications for obtaining regional regulatory approval based on varied endpoint requirements.
Conclusions:
- Various statistical methods exist for designing and analyzing MRCTs with two primary endpoints.
- Systematic comparison aids in selecting appropriate approaches to meet diverse regional regulatory demands.
- The choice of testing strategy and error control significantly influences trial outcomes and approval.
Related Concept Videos
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Clinical Trials
There are four phases in a clinical trial. A phase one...
Comparing the Survival Analysis of Two or More Groups
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
